Deutsche Bank AG bought a new position in Stepan Company (NYSE:SCL - Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 23,364 shares of the basic materials company's stock, valued at approximately $1,302,000. Deutsche Bank AG owned about 0.10% of Stepan as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. Goldman Sachs Group Inc. raised its position in Stepan by 195.5% in the fourth quarter. Goldman Sachs Group Inc. now owns 299,970 shares of the basic materials company's stock worth $14,207,000 after acquiring an additional 198,457 shares during the period. Bank of New York Mellon Corp purchased a new position in Stepan in the second quarter valued at approximately $6,836,000. Towle & Co. purchased a new position in Stepan in the first quarter valued at approximately $5,295,000. Bridgeway Capital Management LLC bought a new position in Stepan during the second quarter valued at $5,573,000. Finally, Sei Investments Co. grew its holdings in Stepan by 465.5% during the first quarter. Sei Investments Co. now owns 123,800 shares of the basic materials company's stock valued at $6,188,000 after purchasing an additional 101,907 shares during the period. Hedge funds and other institutional investors own 82.70% of the company's stock.
Stepan Trading Down 0.6%
Shares of SCL opened at $62.44 on Friday. Stepan Company has a twelve month low of $41.82 and a twelve month high of $68.00. The stock has a market cap of $1.42 billion, a PE ratio of -520.33 and a beta of 0.94. The company has a quick ratio of 0.77, a current ratio of 1.15 and a debt-to-equity ratio of 0.20. The business's 50-day moving average price is $60.04 and its 200-day moving average price is $55.04.
Stepan (NYSE:SCL - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The basic materials company reported $1.18 EPS for the quarter, beating analysts' consensus estimates of $0.61 by $0.57. The company had revenue of $684.11 million during the quarter, compared to analyst estimates of $635.85 million. Stepan had a negative net margin of 0.11% and a positive return on equity of 3.90%. Stepan's revenue was up 15.0% compared to the same quarter last year. During the same period last year, the business earned $0.52 earnings per share. On average, equities analysts forecast that Stepan Company will post 2.69 EPS for the current fiscal year.
Stepan Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a $0.395 dividend. This represents a $1.58 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, September 1st. Stepan's dividend payout ratio (DPR) is presently -1,316.67%.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on SCL. Weiss Ratings upgraded Stepan from a "sell (d)" rating to a "sell (d+)" rating in a research note on Wednesday, July 29th. Zacks Research upgraded Stepan from a "strong sell" rating to a "hold" rating in a research note on Monday, July 6th. Wall Street Zen raised Stepan from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Finally, Seaport Research Partners restated a "buy" rating and issued a $85.00 price objective on shares of Stepan in a research note on Friday, August 7th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Reduce".
View Our Latest Research Report on SCL
About Stepan
(
Free Report)
Stepan Company is a global manufacturer of specialty and intermediate chemicals, primarily known for its development and production of surfactants and related specialty products. The company's portfolio includes a wide range of ingredients used to enhance the performance of consumer and industrial formulations, such as emulsifiers, foam control agents, odor control agents, antimicrobial products and performance additives. These products are integral components in cleaning solutions, personal care items, agrochemical formulations, coatings, oilfield treatments and polymer systems.
Serving a diverse set of end-markets, Stepan's offerings address both consumer-facing and industrial applications.
Featured Stories
Want to see what other hedge funds are holding SCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stepan Company (NYSE:SCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Stepan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stepan wasn't on the list.
While Stepan currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.